Bourgeon Capital Management’s Zivo Bioscience, Inc. Common Stock ZIVO Stock Holding History

Bourgeon Capital Management’s Portfolio ZIVO Stock Details ZIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-5	Closed	-$41	–	424
2023 Q3	$41	Hold	5	–	–	﹤0.01%	393
2023 Q2	$76	Hold	5	–	–	﹤0.01%	329
2023 Q1	$96	Hold	5	–	–	﹤0.01%	314
2022 Q4	$78	Hold	5	–	–	﹤0.01%	368
2022 Q3	$0	Hold	5	–	–	﹤0.01%	462
2022 Q2	$0	Hold	5	–	–	﹤0.01%	319
2022 Q1	$0	Hold	5	–	–	﹤0.01%	315
2021 Q4	$0	Buy	+5	New	+$105	﹤0.01%	299

Other funds holding ZIVO

BCWM

Bartlett & Co Wealth Management Cincinnati, Ohio $7.99B AUM 20.76% 1-Year Est. Return

Bourgeon Capital Management's ZIVO Position: Q4 2023 in Review

Bourgeon Capital Management sold out of Zivo Bioscience, Inc. Common Stock (ZIVO) in Q4 2023, closing a stake of 5 shares — an estimated $41 sold.

Bourgeon Capital Management first reported a position in ZIVO in Q4 2021 and held it in 8 quarters. The position peaked at $96 in Q1 2023. 2 funds tracked by Wall St. Rank hold ZIVO as of Q4 2023.

Bourgeon Capital Management reported no remaining Zivo Bioscience, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Bourgeon Capital Management sold 5 Zivo Bioscience, Inc. Common Stock shares in Q4 2023, an estimated $41.
Bourgeon Capital Management first reported a position in Zivo Bioscience, Inc. Common Stock in Q4 2021 and held it in 8 quarters.
Bourgeon Capital Management's Zivo Bioscience, Inc. Common Stock position peaked at $96 in Q1 2023.
2 funds tracked by Wall St. Rank held Zivo Bioscience, Inc. Common Stock as of Q4 2023.

Based on Bourgeon Capital Management's 13F filing for Q4 2023, filed 30 Jan 2024.